VIM and hepatocellular carcinoma: Mima et al. reported that poor tumor differentiation, vascular invasion, extrahepatic recurrence, and shorter disease-free survival after surgery were confirmed in HCC patients with low expression of E-cadherin and high expression of Vimentin [27].